SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
05 Giugno 2024 - 10:09PM
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to
solving musculoskeletal disorders of the sacropelvic anatomy, today
announced that the company will be participating in the upcoming
2024 Truist Securities MedTech Conference in Boston. Management
will be hosting a fireside chat on Tuesday, June 18, at 3:40 p.m.
Eastern Time / 12:40 p.m. Pacific Time.
Investors interested in listening to the conference call may do
so by registering at this link:
https://wsw.com/webcast/truist5/sibn/2067200. Live audio of the
webcast will be available on the “Investors” section of the
company’s website at: www.si-bone.com. The webcast will be archived
and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in
technology for surgical treatment of musculoskeletal disorders of
the sacropelvic anatomy. Since pioneering minimally invasive
surgery of the SI joint in 2009, SI-BONE has supported over 3,700
surgeons in performing a total of more than 100,000 sacropelvic
procedures. A unique body of clinical evidence supports the use of
SI-BONE’s technologies, including four randomized controlled trials
and over 130 peer reviewed publications. SI-BONE has leveraged its
leadership in minimally invasive SI joint fusion to commercialize
novel solutions for adjacent markets, including adult deformity,
spinopelvic fixation, and pelvic trauma.
For additional information on the company or the
products including risks and benefits, please visit
www.si-bone.com.
iFuse Bedrock Granite, iFuse-TORQ, SI-BONE and
iFuse INTRA are registered trademarks of SI-BONE, Inc. ©2024
SI-BONE, Inc. All Rights Reserved.
Investor Contact: Saqib Iqbal
investors@si-bone.com
Grafico Azioni SI BONE (NASDAQ:SIBN)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni SI BONE (NASDAQ:SIBN)
Storico
Da Dic 2023 a Dic 2024